CD22 and acute lymphoblastic leukemia: Flow cytometry, as illustrated by patient SA24 (Fig. 4a), demonstrated that 5 of 10 patients with B-ALL with progression had negative or low CD19 expression with preserved CD22, using a 90% threshold (Fig. 4b and Table 2).